hims semaglutide fda shortage Drug compounders sue over declaration ending Wegovy Wegovy maker ends partnership with – fda semaglutide shortage resolved feb

Semaglutide is a once-weekly medication specifically because it has an extremely long half-life of approximately seven days

In June 2023, Lilly reported that Orforglipron led to an average weight loss of up to 14.7% over 36 weeks in adults with obesity or overweight based on Phase II trial results

This is especially true for people at risk of a deficiency, including older adults

How IP intelligence de-risks R&D and drives commercial success in green chemistry Green chemistry has moved from a niche academic discipline into a central pillar of industrial strategy

Each compounded medication undergoes rigorous third party testing to ensure consistent quality and safety